SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: John Metcalf who wrote (4141)4/24/1998 10:35:00 PM
From: Peter Singleton  Read Replies (1) | Respond to of 6136
 
Steve, I agree with John. I think we can count on AGPH's public comments as being material. Further, in the current environment, there's not much they could say, I think, that would boost the stock short term. The market is saying "so what" to positive news, and severely punishing not so positive news.

Peter



To: John Metcalf who wrote (4141)4/25/1998 12:06:00 AM
From: Steve Fancy  Respond to of 6136
 
John I appreciate the post and an attempt to make me feel better about this company. Sounds though like you were smart enough to get out when a lot of the insiders did. I bought more on good faith.

They went so far as to stick a one liner on their website regarding these phase III trials. In light of this, for the sake of shareholders, why not issue a small simple press release, reminding the world that they may not be a one drug company for ever. Somehow I don't view stating the facts as pumping the stock, instead I feel it's they're responsibility to me. I also don't expect time frames darn it...just plain simple progress reports when there's progress to be reported. Instead, they're selling they're stock off.

I can't decipher from your post whether you still hold any AGPH or not...if so I wish you luck.

regards,

sf